Serum sclerostin is an independent predictor of mortality in hemodialysis patients

BACKGROUND: Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. The purpose of this study was to test whether serum Scl would be associated with mortality...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMC Nephrol
Κύριοι συγγραφείς: Gonçalves, Flávia Letícia Carvalho, Elias, Rosilene M, dos Reis, Luciene M, Graciolli, Fabiana G, Zampieri, Fernando Godinho, Oliveira, Rodrigo B, Jorgetti, Vanda, Moysés, Rosa MA
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2014
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265422/
https://ncbi.nlm.nih.gov/pubmed/25465028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-190
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια